These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7781490

  • 1. Lack of effect of CS-045, a new antidiabetic agent, on insulin secretion in the remnant pancreas after 90% pancreatectomy in rats.
    Inoue Y, Tanigawa K, Nakamura S, Xu G, Kawaguchi M, Kato Y, Tamura K.
    Diabetes Res Clin Pract; 1995 Jan; 27(1):19-26. PubMed ID: 7781490
    [Abstract] [Full Text] [Related]

  • 2. Nicotinamide, a poly (ADP-ribose) synthetase inhibitor, ameliorates B-cell function in partially depancreatized rats.
    Inoue Y, Tanigawa K, Nakamura S, Kato Y, Tamura K, Nakase A.
    Diabetes Res Clin Pract; 1993 Jan; 22(1):19-27. PubMed ID: 8137712
    [Abstract] [Full Text] [Related]

  • 3. Effect of chronic vanadate administration in partially depancreatized rats.
    Nakamura S, Tanigawa K, Kawaguchi M, Inoue Y, Xu G, Nagami H, Teramoto M, Kato Y, Tamura K.
    Diabetes Res Clin Pract; 1995 Jan; 27(1):51-9. PubMed ID: 7781494
    [Abstract] [Full Text] [Related]

  • 4. Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide.
    Masuda K, Okamoto Y, Tsuura Y, Kato S, Miura T, Tsuda K, Horikoshi H, Ishida H, Seino Y.
    Diabetologia; 1995 Jan; 38(1):24-30. PubMed ID: 7744225
    [Abstract] [Full Text] [Related]

  • 5. Prolonged effect of troglitazone (CS-045) on xenograft survival of hybrid artificial pancreas.
    Kawakami Y, Inoue K, Tun T, Hayashi H, Setoyama H, Gu YJ, Cui WX, Imamura M, Iwata H, Ikada Y.
    Cell Transplant; 1997 Jan; 6(5):547-50. PubMed ID: 9331511
    [Abstract] [Full Text] [Related]

  • 6. Troglitazone (CS-045) inhibits beta-cell proliferation rate following stimulation of insulin secretion in HIT-T 15 cells.
    Ohtani KI, Shimizu H, Sato N, Mori M.
    Endocrinology; 1998 Jan; 139(1):172-8. PubMed ID: 9421412
    [Abstract] [Full Text] [Related]

  • 7. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
    Chicco A, Basabe JC, Karabatas L, Ferraris N, Fortino A, Lombardo YB.
    Metabolism; 2000 Oct; 49(10):1346-51. PubMed ID: 11079827
    [Abstract] [Full Text] [Related]

  • 8. Insulin-sparing effects of troglitazone in rat pancreatic islets.
    Bollheimer LC, Troll S, Landauer H, Wrede CE, Schölmerich J, Buettner R.
    J Mol Endocrinol; 2003 Aug; 31(1):61-9. PubMed ID: 12914525
    [Abstract] [Full Text] [Related]

  • 9. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
    Leahy JL, Bumbalo LM, Chen C.
    Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
    [Abstract] [Full Text] [Related]

  • 10. Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis.
    Zhang B, Saku K, Arakawa K.
    Metabolism; 1997 Mar; 46(3):273-81. PubMed ID: 9054469
    [Abstract] [Full Text] [Related]

  • 11. Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus.
    Shimizu K, Shiratori K, Hayashi N, Fujiwara T, Horikoshi H.
    Pancreas; 2000 Nov; 21(4):421-6. PubMed ID: 11075998
    [Abstract] [Full Text] [Related]

  • 12. Antidiabetic activity of white skinned sweet potato (Ipomoea batatas L.) in obese Zucker fatty rats.
    Kusano S, Abe H.
    Biol Pharm Bull; 2000 Jan; 23(1):23-6. PubMed ID: 10706405
    [Abstract] [Full Text] [Related]

  • 13. Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.
    Fujiwara T, Wada M, Fukuda K, Fukami M, Yoshioka S, Yoshioka T, Horikoshi H.
    Metabolism; 1991 Nov; 40(11):1213-8. PubMed ID: 1943750
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
    Chen S, Noguchi Y, Izumida T, Tatebe J, Katayama S.
    J Hypertens; 1996 Nov; 14(11):1325-30. PubMed ID: 8934361
    [Abstract] [Full Text] [Related]

  • 15. Troglitazone stimulates pancreatic growth in normal rats.
    Jia DM, Otsuki M.
    Pancreas; 2002 Apr; 24(3):303-12. PubMed ID: 11893940
    [Abstract] [Full Text] [Related]

  • 16. Effect of aging on B-cell function and replication in rat pancreas after 90% pancreatectomy.
    Tanigawa K, Nakamura S, Kawaguchi M, Xu G, Kin S, Tamura K.
    Pancreas; 1997 Jul; 15(1):53-9. PubMed ID: 9211493
    [Abstract] [Full Text] [Related]

  • 17. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats.
    Shimabukuro M, Zhou YT, Lee Y, Unger RH.
    J Biol Chem; 1998 Feb 06; 273(6):3547-50. PubMed ID: 9452481
    [Abstract] [Full Text] [Related]

  • 18. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
    Berkowitz K, Peters R, Kjos SL, Goico J, Marroquin A, Dunn ME, Xiang A, Azen S, Buchanan TA.
    Diabetes; 1996 Nov 06; 45(11):1572-9. PubMed ID: 8866563
    [Abstract] [Full Text] [Related]

  • 19. Thiazolidinediones (AD-4833 and CS-045) improve hepatic insulin resistance in streptozotocin-induced diabetic rats.
    Tominaga M, Igarashi M, Daimon M, Eguchi H, Matsumoto M, Sekikawa A, Yamatani K, Sasaki H.
    Endocr J; 1993 Jun 06; 40(3):343-9. PubMed ID: 7920888
    [Abstract] [Full Text] [Related]

  • 20. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
    Okuno A, Ikeda K, Shiota M, Fujiwara T, Yoshioka S, Sugano T, Horikoshi H.
    Metabolism; 1997 Jun 06; 46(6):716-21. PubMed ID: 9186311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.